Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joren Callaert

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patientsKim Taeymans, Marc Bosiers, Koen Deloose, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 30, 2017
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb IschemiaMarc Bosiers, Joren Callaert, Koen Keirse, et al.
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 29, 2025
A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesionsKoen Deloose, Jan Gielis, Lieven Maene, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 12, 2013
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 31, 2019
EVOLUTION Study: 12-month resultsMarc Bosiers, Koen Deloose, Joren Callaert, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|July 19, 2025
Safety and Efficacy of Treatment With the Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Atherosclerotic Disease: 12 and 24-Month Outcome of the T.I.N.T.I.N. Physician-Initiated TrialKoen Deloose, Laura Drudi, Jürgen Verbist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2018
Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD studyMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Surgical Technology International|October 12, 2017
AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular ProceduresEmily Benham, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|October 22, 2014
Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|April 18, 2019
One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patientsKim Taeymans, Marc Bosiers, Koen Deloose, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 30, 2017
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb IschemiaMarc Bosiers, Joren Callaert, Koen Keirse, et al.
The Journal of Cardiovascular Surgery|May 27, 2017
BeGraft Peripheral PMCF Study: 12-month resultsKoen Deloose, Marc Bosiers, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 29, 2025
A Belgian physician-initiated trial investigating the LifeStream peripheral stent graft system for the treatment of complex TASC C and D iliac lesionsKoen Deloose, Jan Gielis, Lieven Maene, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|December 12, 2013
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trialMarc Bosiers, Koen Deloose, Joren Callaert, et al.
The Journal of Cardiovascular Surgery|January 31, 2019
EVOLUTION Study: 12-month resultsMarc Bosiers, Koen Deloose, Joren Callaert, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|July 19, 2025
Safety and Efficacy of Treatment With the Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Atherosclerotic Disease: 12 and 24-Month Outcome of the T.I.N.T.I.N. Physician-Initiated TrialKoen Deloose, Laura Drudi, Jürgen Verbist, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2018
Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD studyMarc Bosiers, Koen Deloose, Giovanni Torsello, et al.
Pageof 3